Thyroxine binding to transthyretin (TTR) variants - Two variants (TTR Pro 55 and TTR met 111) with a particularly low binding affinity

European Journal of Endocrinology

Volumn 135, Issue 2, 1996, Pages 226-230

  Almeida, Maria Rosário ^a   Saraiva, Maria João ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN; THYROXINE;

ARTICLE; CASE REPORT; HUMAN; MUTATION; PRIORITY JOURNAL; THYROID DISEASE;

EID: 0029831901     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350226     Document Type: Article

References (30)

1. Saraiva MJM. Transthyretin mutations in health and disease. Hum Mutat 1995;5:191-6
2. Rosen HN, Moses AC, Murrell JR, Liepnieks JJ, Benson MD. Thyroxine interactions with transthyretin: comparison of 10 different naturally occurring human transthyretin variants. J Clin Endocrinol Metab 1993;77:370-4
3. Murrel JR, Schoner RG, Liepnicks JJ, Rosen H, Moses AC, Benson MD. Production and functional analysis of normal and variant recombinant human transthyretin proteins. J Biol Chem 1992;267(23):16595-600
4. Curtis AJ, Scrimshaw BJ, Topliss DJ, Stockigt JR, George PM, Barlow JW. Thyroxine binding by human transthyretin variants: mutations at position 119, but not position 54, increase thyroxine binding affinity. J Clin Endocrinol Metab 1994; 78:459-62
5. Moses AC, Rosen HN, Moller DE, Tsuzuki S, Haddow JE, Lawlor J, et al. A point mutation in transthyretin Increases affinity for thyroxine binding and produces euthyroid hyperthyroxinemia. J Clin Invest 1990;86:2025-33
6. Scrimshaw BJ, Fellowes AP, Palmer BN, Croxson MS, Stockigt JR, George PM. A novel variant of transthyretin (prealbumin), Thr 119 to Met associated with increased thyroxine binding. Thyroid 1991;2:21-6
7. 4 binding affinity. Submitted
8. Almeida MR, Ferlini A, Forabosco A, Gawinowicz MA, Costa PP, Salvi F, et al. Transthyretin variants (TTR Ala 49 and TTR Gin 89) in two Sicilian kindreds with hereditary amyloidosis. Hum Mutat 1992;1:211-5
9. Jacobson DR, McFarlin DE, Kane I, Buxbaum JN. Transthyretin Pro 55 a variant associated with early-onset, agressive, diffuse amyloidosis with cardiac and neurologic Involvement. Hum Genet 1992;89:353-6
10. Almeida MR, Hesse A, Steinmetz A, Maisch B, Altland K, Linke RP, et al. Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Cardiol 1991;86:567-71
11. Almeida MR, Andreu FL, Qués MM, Costa PP, Saraiva MJ. Transthyretin Ala 71: a new transthyretin variant in a Spanish family with familial amyloidotic polyneuropathy. Hum Mutat 1993;2:420-1
12. Almeida MR, Altland K, Rauh S, Gawinowicz MA, Morelra P, Costa PP, et al. Characterization of a basic transthyretin variant TTR-Arg 102 in the German population. Biochem Biophys Acta 1991;1097:224-6
13. Ranlov I, Alves I, Ranlov PJ, Husby G, Costa PP, Saraiva MJM. A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine 111 variant in serum from patients and carriers. Am J Med 1992;93:3-8
14. Furuya H, Saraiva MJM, Gawinowicz MA, Alves IL, Costa PP, Sasakl H, et al. Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP).-Biochemistry 1991;30:2415-21
15. McCutchen SL, Colon W, Kelly JW. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 1993;32:12119-27
16. Somack R, Andrea TA, Jorgensen EC. Thyroid hormone binding to human serum prealbumin and rat liver nuclear receptor: kinetics. contribution of the hormone phenolic hydroxyl group, and accomodation of hormone side chain bulk. Biochemistry 1982;21:163-70
17. Lans MC, Klasson-Wehler E, Willemsen M, Meussen E, Safe S, Brouwer A. Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem-Biol Interact 1993;88:7-21
18. Laurell CB. Quantitative estimation of proteins by electrophoresis in antibody-containing agarose gel. In: Peeters H, editor. Protein and biological fluids. vol 14. Amsterdam: Elsevier, 1967:499-502
19. Lim CF, Munro SLA, Wynne KN, Topliss DJ, Stockigt JR. Influence of non-esterified fatty-acids and lysolecithins on thyroxine binding to thyroxine-binding globulin and transthyretin. Thyroid 1995;5(4):319-24
20. Blake CCF, Geisow MJ, Oatley SJ, Rerat B, Rerat C. Structure of prealbumin: secondary, tertiary and quaternary interaction determined by Fourier refinement at 1.8 angstrom. J Mol Biol 1978;121:339-56
21. Steinrauf LK, Hamilton JA, Braden BC, Murrel JR, Benson MD. X-ray crystal structure of the Ala-109-Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia. J Biol Chem 1993;268:2425-30
22. Hamilton JA, Steinrauf LK, Braden BC, Liepniecks J, Benson MD, Holmgren G, et al. The X-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-Met variant to 1.7-Å resolution. J Biol Chem 1993;268:2416-22
23. Syversen V, Mostad A, Sletten K, Husby G, Ranlov PJ. A transthyretin variant from a patient with familial amyloidotic cardiomyopathy. A computer graphic study. In: Costa PP, Freitas AF, Saraiva MJM, editors. Familial amyloidotic polyneuropathy and other transthyretin related disorders. Porto: Arquivos de Medicina, 1990:59-64
24. Damas AM, Terry CJ, Blake CCF. Conformational changes in variants of human transthyretin. In: Costa PP, Freitas AF, Saraiva MJM, editors. Familial amyloidotic polyneuropathy and other transthyretin related disorders. Porto: Arquivos de Medicina, 1990:55-7
25. Nordvag B, Ranlov I, El-Gewely MR, Husby G. Two transthyretin variants, Ser 6 and Met 111, in a Danish kindred with familial amyloid cardiomyopathy: implications for serum TTR and thyroxine hormone levels. Amyloid: Int J Exp Clin Invest 1995;2:241-50
26. Sebastiäo P, Dauter Z, Saraiva MJ, Damas AM. Crystallization and preliminary X-ray diffraction studies of Leu-55-Pro variant transthyretin. Acta Crystallogr 1996 D52. In press
27. McKinney JD, Chae K, Oatley SJ, Blake CF. Molecular interactions of toxic chlorinated dibenzo-p-dioxins and dibenzofurans with thyroxine binding prealbumin. J Med Chem 1985;28:375-81
28. Kohrle J, Fang SL, Yang Y, Irmscher K, Hesch RD, Pino S. et al. Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinology 1989;125:532-7
29. Smith TJ, Davis FB, Deziel MR, Davis PJ, Ramsden DB, Schoeni M. Retinoic acid inhibition of thyroxine binding to human transthyretin. Biochem Biophys Acta 1994;1199:76-80
30. Zanotti G, D'Acunto MR, Malepli G, Folli C, Berni R. Crystal structure of transthyretin-retinoic-acid complex. Eur J Biochem 1995;234:563-9